Medical Xpress news
Medical Xpress / Key protein found to protect cartilage, offering new hope for osteoarthritis treatment
Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations. The disease is characterized ...
Medical Xpress / Home-based chemotherapy: Pilot study demonstrates safety and feasibility
In a study published in NEJM Catalyst, Mayo Clinic researchers demonstrate that chemotherapy can be safely delivered in patients' homes. The study evaluated Mayo Clinic's Cancer CARE Beyond Walls (Connected Access and Remote ...
Medical Xpress / Genes tied to impulse control play a major role in addiction risk
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences—not from genes that specifically influence substance ...
Medical Xpress / Engineered tissue offers hope for children born with 'missing' esophagus
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus—the food pipe—shown to safely replace a full section of the organ and restore normal ...
Medical Xpress / Large imaging study changes understanding of the origins of Parkinson's rest tremor
A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In contrast, tremor appears to be associated with relatively better-preserved dopamine function. Researchers ...
Medical Xpress / From pathology image to biological discovery: LazySlide uses foundation models to connect tissue images and RNA data
Microscopic images of human tissue are a cornerstone of biomedical research and clinical diagnostics. Yet despite their importance, these images often remain difficult to analyze systematically and to connect with other types ...
Medical Xpress / Weight-loss drug semaglutide does not slow Alzheimer's disease, two clinical trials find
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the first large Phase III randomized controlled trials on the topic published in The Lancet.
Medical Xpress / Identifying older adults at risk for heat-related illness can help health systems prepare
Nationally, heat-related mortality has risen by nearly 17% per year since 2016. As a result, New York City now issues heat alerts and opens cooling centers when the heat index is forecast to reach 95 degrees Fahrenheit or ...
Medical Xpress / Diabetes outcomes worsen after insurance loss, study finds
Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University.
Medical Xpress / Botox: A new therapeutic approach to treating finger ulcers and gangrene
Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as acute digital ischemia (which ...
Medical Xpress / Promising active substance against hepatitis E identified
Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...
Medical Xpress / Tracking sleep with an app? Why insomnia sufferers may feel worse, not better
The increasing availability of sleep monitoring apps, and rising interest in sleep health, has led to a sharp increase in people tracking their rest. But these apps might not give people an accurate image of their sleep, ...